We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




DNA Replication Determines Cell Cycle Duration

By LabMedica International staff writers
Posted on 10 Jul 2018
Print article
Image: Shown here in green is IkBa, the inhibitor of NF-kappaB and regulator of the immune system. The red region highlights an ubiquitin-independent degron (Photo courtesy of Wikimedia Commons).
Image: Shown here in green is IkBa, the inhibitor of NF-kappaB and regulator of the immune system. The red region highlights an ubiquitin-independent degron (Photo courtesy of Wikimedia Commons).
An international team of cell and molecular biologists found that DNA damage and danger of cancer development were minimized by a molecular mechanism that delays cell division (mitosis) until two complete copies of the cell's genome are created.

To maintain genome stability, cells have to replicate their DNA before dividing. Upon completion of bulk DNA synthesis, the mitotic kinases CDK1 and PLK1 become active and drive entry into mitosis.

Investigators at the Karolinska Institutet (Stockholm, Sweden) and the University of Sussex (United Kingdom) tested the hypothesis that DNA replication determined the timing of mitotic kinase activation. To do this, they generated a double-degron system to rapidly deplete the essential DNA replication-initiation factor CDC6 (Cell division control protein 6 homolog). A degron is a portion of a protein that is important in regulation of protein degradation rates. Known degrons include short amino acid sequences, structural motifs and exposed amino acids (often lysine or arginine) located anywhere in the protein. Some proteins contain multiple degrons.

The investigators reported in the June 28, 2018, online edition of the journal Molecular Cell that untransformed human cells shortened the cell cycle and prematurely entered mitosis in the absence of DNA replication. Using RNAi and inhibitors to independently target DNA replication licensing or firing, they found similar results in cancer cells. They also found that abrogating CHK1 activity in transformed cells, or CHK1 and p38 activity in untransformed cells enhanced CDK activation specifically upon G1/S transition, supporting the notion of a DNA replication checkpoint in human cells.

In the presence of DNA replication, inhibition of CHK1 and p38 led to premature activation of mitotic kinases, which induced severe replication stress. These results demonstrated that, rather than merely being a cell cycle output, DNA replication was an integral signaling component that restricted activation of mitotic kinases. DNA replication thus functioned as a brake that determined cell cycle duration.

"By creating cells that cannot copy their DNA and by following protein activities over time in single cells, we found that DNA replication blocks the enzymes that trigger cell division. Immediately after DNA replication is completed, the machinery that starts cell division is activated. This fundamental mechanism contributes to determining when human cells will divide," said senior author Dr. Arne Lindqvist, senior researcher in cell and molecular biology at Karolinska Institutet.

Related Links:
Karolinska Institutet
University of Sussex

Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Ultrasonic Cleaner
UC 300 Series
New
Calprotectin Assay
Fecal Calprotectin ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.